Галактокиназа ферменті: құрылымы, қасиеттері және галактоземиямен байланысы

Enzyme

Galactokinase is an enzyme (phosphotransferase) that facilitates the phosphorylation of α D galactose to galactose 1 phosphate at the expense of one molecule of ATP. Galactokinase catalyzes the second step of the Leloir pathway, a metabolic pathway found in most organisms for the catabolism of α D galactose to glucose 1 phosphate. plants, and humans. GHMP is an abbreviation referring to its original members: galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase. Members of the GHMP superfamily have great three dimensional similarity despite only ten to 20% sequence identity. These enzymes contain three well conserved motifs (I, II, and III), the second of which is involved in nucleotide binding and has the sequence Pro X X X Gly Leu X Ser Ser Ala.

Galactokinases across different species display a great diversity of substrate specificities. E. coli galactokinase can also phosphorylate 2 deoxy D galactose, 2 amino deoxy D galactose, 3 deoxy D galactose and D fucose. The enzyme cannot tolerate any C 4 modifications, but changes at the C 2 position of D galactose do not interfere with enzyme function. Both human and rat galactokinases are also able to successfully phosphorylate 2 deoxy D galactose. Galactokinase from S. cerevisiae, on the other hand, is highly specific for D galactose and cannot phosphorylate glucose, mannose, arabinose, fucose, lactose, galactitol, or 2 deoxy D galactose. Moreover, the kinetic properties of galactokinase also differ across species. and structure based protein engineering. The corresponding broadly permissive sugar anomeric kinases serve as a cornerstone for in vitro and in vivo glycorandomization.

Recently, the roles of active site residues in human galactokinase have become understood. Asp 186 abstracts a proton from C1 OH of α D galactose, and the resulting alkoxide nucleophile attacks the γ phosphorus of ATP. A phosphate group is transferred to the sugar, and Asp 186 may be deprotonated by water. Nearby Arg 37 stabilizes Asp 186 in its anionic form and has also been proven to be essential to galactokinase function in point mutation experiments. Both the aspartic acid and arginine active site residues are highly conserved among galactokinases.

Galactosemia, a rare metabolic disorder characterized by decreased ability to metabolize galactose, can be caused by a mutation in any of the three enzymes in the Leloir pathway. Galactokinase deficiency, also known as galactosemia type II, is a recessive metabolic disorder caused by a mutation in human galactokinase. About 20 mutations have been identified that cause galactosemia type II, the main symptom of which is early onset cataracts. In lens cells of the human eye, aldose reductase converts galactose to galactitol. As galactose is not being catabolized to glucose due to a galactokinase mutation, galactitol accumulates. This galactitol gradient across the lens cell membrane triggers the osmotic uptake of water, and the swelling and eventual apoptosis of lens cells ensues.